Cargando…
P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428700/ http://dx.doi.org/10.1097/01.HS9.0000969240.88472.88 |
| _version_ | 1785090531761586176 |
|---|---|
| author | Wang, Huafeng Yang, Min Tong, Hongyan Lou, Yinjun Zhu, Honghu Han, Yue Qian, Jiejin Mao, Liping Yang, Chunmei Lu, Ying Zhou, Xinping Shou, Lihong Meng, Haitao Zhou, De Yu, Wenjuan LI, LI Jin, Jie |
| author_facet | Wang, Huafeng Yang, Min Tong, Hongyan Lou, Yinjun Zhu, Honghu Han, Yue Qian, Jiejin Mao, Liping Yang, Chunmei Lu, Ying Zhou, Xinping Shou, Lihong Meng, Haitao Zhou, De Yu, Wenjuan LI, LI Jin, Jie |
| author_sort | Wang, Huafeng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428700 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287002023-08-17 P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL Wang, Huafeng Yang, Min Tong, Hongyan Lou, Yinjun Zhu, Honghu Han, Yue Qian, Jiejin Mao, Liping Yang, Chunmei Lu, Ying Zhou, Xinping Shou, Lihong Meng, Haitao Zhou, De Yu, Wenjuan LI, LI Jin, Jie Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428700/ http://dx.doi.org/10.1097/01.HS9.0000969240.88472.88 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Wang, Huafeng Yang, Min Tong, Hongyan Lou, Yinjun Zhu, Honghu Han, Yue Qian, Jiejin Mao, Liping Yang, Chunmei Lu, Ying Zhou, Xinping Shou, Lihong Meng, Haitao Zhou, De Yu, Wenjuan LI, LI Jin, Jie P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title | P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title_full | P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title_fullStr | P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title_full_unstemmed | P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title_short | P584: VENETOCLAX PLUS HOMOHARRINGTONINE-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR ADULTS WITH ACUTE MYELOID LEUKAEMIA: A MULTICENTRE, SINGLE-ARM, PHASE 2 TRIAL |
| title_sort | p584: venetoclax plus homoharringtonine-based chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428700/ http://dx.doi.org/10.1097/01.HS9.0000969240.88472.88 |
| work_keys_str_mv | AT wanghuafeng p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT yangmin p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT tonghongyan p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT louyinjun p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT zhuhonghu p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT hanyue p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT qianjiejin p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT maoliping p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT yangchunmei p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT luying p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT zhouxinping p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT shoulihong p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT menghaitao p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT zhoude p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT yuwenjuan p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT lili p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial AT jinjie p584venetoclaxplushomoharringtoninebasedchemotherapyasfirstlinetreatmentforadultswithacutemyeloidleukaemiaamulticentresinglearmphase2trial |